Concepedia

Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma

Chunmeng Zhang, Pranita Atri, Palanisamy Nallasamy, Seema Parte, Sanchita Rauth, Rama Krishna Nimmakayala, Saravanakumar Marimuthu, Ramakanth Chirravuri‐Venkata, Rakesh Bhatia, Sushanta Halder,

Cancer Letters · 2022 · 17 citations · 30 references

DOIFull text

Open access

Concepts

References

30

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations

, , +17

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni et al. · New England Journal of Medicine · 2019 · 2.2K citations · Full text

, , +17

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Pascal Hammel, F. Huguet, Jean‐Luc Van Laethem et al. · JAMA · 2016 · 1.1K citations

, , +13

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Marianne Sinn, Marcus Bahra, Torsten Liersch et al. · Journal of Clinical Oncology · 2017 · 296 citations

, , +13

Inhibition of <b> <i>MUC4</i> </b> Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

Ajay P. Singh, Nicolas Moniaux, Subhash C. Chauhan et al. · Cancer Research · 2004 · 231 citations

, , +15